Background glaucoma Shape Background glaucoma Shape Background glaucoma Shape
Grants > Why Certain Retina Ganglion Cells Stay Strong in Glaucoma Updated On: Ene. 21, 2025
National Glaucoma Research Grant

Why Certain Retina Ganglion Cells Stay Strong in Glaucoma

Protecting & Regenerating the Optic Nerve
Mengya Zhao, PhD

Principal Investigator

Mengya Zhao, PhD

University of California, San Francisco

San Francisco, CA, USA

About the Research Project

Program

National Glaucoma Research

Award Type

Postdoctoral Fellowship

Award Amount

$150,000

Active Dates

July 01, 2024 - June 30, 2026

Grant ID

G2024005F

Mentor(s)

Xin Duan, PhD, University of California, San Francisco

Goals

This project aims to advance glaucoma understanding and treatment using innovative genetic and spatial transcriptomic methods.

Summary

This project focuses on understanding the mechanisms underlying neuronal loss in glaucoma, which can lead to irreversible blindness. This disease variably impacts many eye neurons. Using a combination of cutting-edge techniques, researchers will investigate why certain neurons are more resilient than others. This work could unlock new treatments, offering a breakthrough in glaucoma therapy and eye care.

Unique and Innovative

This proposal uniquely integrates spatial transcriptomics with advanced genetic manipulations to investigate retinal ganglion cell degeneration, maintaining cellular context to unravel glaucoma’s complex molecular landscape. Employing MERFISH allows for unprecedented visualization of RGC transcriptomes in situ, enhancing understanding of cell-specific responses to stress and potential neuroprotective mechanisms. This approach pioneers a comprehensive, spatially-resolved exploration of glaucoma pathophysiology.

Foreseeable Benefits

Upon completion, this study is expected to offer novel insights into the cellular mechanisms of glaucoma, paving the way for targeted therapies that can potentially halt or reverse vision loss. The integration of spatial transcriptomics could also set a new standard for studying neurodegenerative diseases more broadly, benefiting both clinical approaches and basic neurological research.